期刊文献+

2型糖尿病高危人群的早期筛查分析 被引量:1

Analysis of early screening in high-risk population for type 2 diabetes mellitus
下载PDF
导出
摘要 [目的]探讨正常糖耐量(NGT)伴胰岛素抵抗(IR)人群中2型糖尿病高危人群的判别方法.[方法]对204例NGT受试者进行(6.01±0.35)年的随访研究,以随访时是否发展为前驱糖尿病和或2型糖尿病为标准,分析基线时受试者空腹胰岛素(Fins)、胰岛素曲线下面积(AUCins)、稳态模型胰岛素抵抗指数(HOMA-IR)、稳态模型胰岛β细胞分泌(HOMA-β)及胰岛素早期分泌指数(ΔI30/ΔG30)等指标的受试者工作特征(ROC)曲线下面积,选择最大ROC曲线下面积为指标,以该指标约登指数最大分值为最佳诊断临界值,根据其将基线时204例NGT受试者分为高危组和低危组,比较两组基线时IR情况及随访时前驱糖尿病和或2型糖尿病的发病率.[结果]Fins,AUCins,HOMA-IR,HOMA-β和ΔI30/ΔG30等指标的ROC曲线下面积分别为0.805,0.848,0.825,0.632和0.753,以AUCins的ROC曲线下面积为最大,其最佳诊断临界值为108.43 mU/L.与低危组比较,高危组前驱糖尿病或2型糖尿病发病率显著增高(29.41%,2.21%,P<0.001),Fins,AUCins,HOMA-IR等指标亦均显著增高(P<0.001).[结论]2型糖尿病高危人群也存在于NGT受试者中.以AUCins≥108.43 mU/L为诊断临界值可初步筛查2型糖尿病的高危人群. OBJECTIVE To study the discriminate method in high-risk population with normal glucose tolerance(NGT)and insulin resistance(IR)for type 2diabetes mellitus(T2DM).METHODS204 subjects with NGT were followed up for 6.01±0.35 years.The subjects were followed up whether development of prediabetes and/or T2 DM as standard,it was analyzed at baseline that the area under receiver operating characteristic(ROC)curve of indexes of fasting insulin(Fins),area under the curve of insulin(AUCins),homeostasis model assessment of insulin resistance(HOMA-IR),homeostasis model assessment ofβ-cell function(HOMA-β)andΔI30/ΔG30 and so on,and the biggest area under the ROC curve was choosed as an index,and the highest score of Yauden's index was as the optimal diagnostic critical value.According to the diagnostic threshold baseline,the 204 subjects with NGT were divided into high-risk and low-risk groups,and the status of IR at baseline and the incidence of prediabetes and/or T2 DM at following up were compared between two groups.RESULTS The areas under the ROC curve of indexes of Fins,AUCins,HOMA IR,HOMA-βandΔI30/ΔG30were 0.805,0.848,0.825,0.848 and 0.825,respectively,and the area under ROC curve of AUCins was as the biggest,and its optimal diagnostic critical value was 108.43 mU/L.The incidence of prediabetes and/or T2DM(29.41%,2.21%,)and the indexes of Fins,AUCins,HOMA-IR increased significantly in high risk group than in low risk group(P〈0.001).CONCLUSION The high-risk population for T2 DM also exist in NGT subjects,and is preliminarily screened with the AUCins≥108.43mU/L as diagnosis threshold.
出处 《延边大学医学学报》 CAS 2014年第4期297-300,共4页 Journal of Medical Science Yanbian University
关键词 糖尿病 正常糖耐量 胰岛素抵抗 胰岛素曲线下面积 早期筛查 diabetes mellitus normal glucose tolerance Insulin resistance insulin area under curve early screening
  • 相关文献

参考文献19

  • 1Tripathy D,Carisson M,Almgren P,et al..Insilin secretion and insulin sensitivity in relation to glucose tolerance:lessons from the botnia study[J].Diabetes,2000,49(6):975-980.
  • 2Stewart MW,Humphriss DB,Berrish ST,et al..Features of syndrome X in first-degree relatives of NIDDM patients[J].Diabetes Care,1995,18(7):1020-1022.
  • 3American Diabetes Association.Standards of medical care in diabetes 2013[J].Diabetes Care,2013,36(Suppl1):S11-S66.
  • 4Matthews DR,Hosker JP,Rudenski AS,et al..Homeostasis model assessment:insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man[J].Diabetologia,1985,28(7):412-419.
  • 5Matsuda M,DeFronzo RA.Insulin sensitivity indices obtained from oral glucose tolerance testing:comparison with the euglycemic insulin clamp[J].Diabetes Care,1999,22(9):1462-1470.
  • 6Bonora E,Targher G,Alberich M,et al..Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity:studies in subjects with various degrees of glucose intolerance and insulin sensitivity[J].Diabetes Care,2000,23(1):57-63.
  • 7Retnakaran R,Qi Y,Goran MI,et al..Evaluation of proposed oral disposition index measures in relation to the actual disposition index[J].Diabet Med,2009,26(12):1198-1203.
  • 8Li G,Zhang P,Wang J,et al..The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing diabetes prevention study:a20-year follow-up study[J].Lancet,2008,371(9626):1783-1789.
  • 9Cefalu WT.Steps toward the meaningful translation of prevention strategies for type 2 diabetes[J].Diabetes Care,2012,35(4):663-665.
  • 10Mortaz S,Wessman C,Duncan R,et al..Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada:a markov model simulation[J].Clinicoecon Outcomes Res,2012,4:91-97.

二级参考文献19

  • 1International diabetes federation. Diabetes atlas fifth, edition, [ M/OL ] . ( 2011-11-14 ) [ 2012-04-17 ] . http://www, idf. org/ atlasmap/atlasmap. Accessed.
  • 2Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med,2010,362 : 1090-1101.
  • 3Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980 : systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2. 7 million participants. Lancet,2011, 378:31-40.
  • 4Rhee MK, Ziemer DC, Kolm P, et al. Postchallenge glucose rises with increasing age even when glucose tolerance is normal. Diabet Med, 2006,23 : 1174 -1179.
  • 5Abdul-Ghani MA, Tripathy D, DeFmnzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care ,2006,29 : 1130-1139.
  • 6Ning F, Qiao Q, Tuomilehto J, et al. Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities? . Diabetes Metab Res Rev,2010, 26: 245-253.
  • 7Szoke E, Shrayyef MZ, Messing S, et al. Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance. Diabetes Care,2008, 31:539-543.
  • 8Toyoda K, Fukushima M, Mitsui R, et al. Factors responsible for age-related elevation in fasting plasma glucose: a cross-sectional study in Japanese men. Metabolism,2008,57:299-303.
  • 9Ferrannini E, Vichi S, Beck-Nielsen H, et al. Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes, 1996,45: 947-953.
  • 10Giaccari A, Sorice G, Muscogiuri G. Glucose toxicity: the leading actor in the pathogenesis and clinical history of type 2 diabetes -mechanisms and potentials for treatment. Nutr Metab Cardiovasc Dis, 2009,19:365-377.

共引文献11

同被引文献11

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部